[{"address1": "Rue Edouard Belin 12", "city": "Mont-Saint-Guibert", "zip": "1435", "country": "Belgium", "phone": "32 10 22 23 55", "website": "https://www.nyxoah.com", "industry": "Medical Instruments & Supplies", "sector": "Healthcare", "longBusinessSummary": "Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.", "fullTimeEmployees": 146, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert  Taub MBA", "age": 76, "title": "Co-Founder & Chairman", "yearBorn": 1947, "fiscalYear": 2023, "totalPay": 139614, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Olivier  Taelman", "age": 52, "title": "CEO & Executive Director", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 882858, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Loic  Moreau", "age": 42, "title": "Chief Financial Officer", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 512683, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bruno  Onkelinx", "title": "Chief Technology Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mikaela  Kirkwood", "title": "Corporate Communication & Investor Relations Manager", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. An  Moonen", "title": "General Counsel", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Inge  Vanwittenbergh", "title": "Global Human Resource Director", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David M. DeMartino", "title": "Chief Strategy Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Remi  Renard", "title": "Chief of Staff", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeyakumar  Subbaroyan", "title": "Chief Clinical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 9.2, "open": 9.3858, "dayLow": 8.98, "dayHigh": 9.3858, "regularMarketPreviousClose": 9.2, "regularMarketOpen": 9.3858, "regularMarketDayLow": 8.98, "regularMarketDayHigh": 9.3858, "beta": 0.575, "forwardPE": -5.3257313, "volume": 3986, "regularMarketVolume": 3986, "averageVolume": 35230, "averageVolume10days": 11827, "averageDailyVolume10Day": 11827, "marketCap": 324510656, "fiftyTwoWeekLow": 4.0, "fiftyTwoWeekHigh": 20.0, "priceToSalesTrailing12Months": 63.28211, "fiftyDayAverage": 8.62255, "twoHundredDayAverage": 8.791459, "currency": "USD", "enterpriseValue": 229657760, "floatShares": 11012411, "sharesOutstanding": 34373000, "sharesShort": 54341, "sharesShortPriorMonth": 56284, "sharesShortPreviousMonthDate": 1717113600, "dateShortInterest": 1719532800, "sharesPercentSharesOut": 0.0016, "heldPercentInsiders": 0.42575002, "heldPercentInstitutions": 0.26650998, "shortRatio": 1.22, "shortPercentOfFloat": 0.003, "bookValue": 3.04, "priceToBook": 2.9957237, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -43207000, "trailingEps": -1.64, "forwardEps": -1.71, "enterpriseToRevenue": 44.785, "enterpriseToEbitda": -5.075, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "NYXH", "underlyingSymbol": "NYXH", "shortName": "Nyxoah SA", "longName": "Nyxoah S.A.", "firstTradeDateEpochUtc": 1619616600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "067cdc20-d2e6-3884-af4a-437fe8703370", "gmtOffSetMilliseconds": -14400000, "currentPrice": 9.107, "targetHighPrice": 20.14, "targetLowPrice": 15.1, "targetMeanPrice": 17.92, "targetMedianPrice": 18.12, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 44302000, "totalCashPerShare": 1.545, "ebitda": -45255000, "totalDebt": 12747000, "quickRatio": 3.6, "currentRatio": 3.941, "totalRevenue": 5128000, "debtToEquity": 14.619, "revenuePerShare": 0.179, "returnOnAssets": -0.21745001, "returnOnEquity": -0.40717998, "freeCashflow": -39521876, "operatingCashflow": -46389000, "revenueGrowth": 1.769, "grossMargins": 0.62246, "operatingMargins": -10.00246, "financialCurrency": "EUR", "trailingPegRatio": null, "__fetch_time": "2024-07-19"}]